SALT LAKE CITY, May 23, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a worldwide leader in personalized medicine, today announced seven new commercial coverage decisions for Prolaris ...
A series of class actions over the exclusion of coverage for GLP-1 weight loss drugs is testing several legal strategies ...
In a groundbreaking decision issued May 21, 2025, the Michigan Court of Appeals handed down a pivotal win for car crash victims across the state, particularly those injured by a negligent family ...
Although the literature has investigated utilization management practices, how they align with clinical practice guidelines is not well understood. 10, 11 A better understanding of this alignment ...
In recent years, the integration of artificial intelligence (AI) into various sectors has been nothing short of revolutionary. One such sector experiencing transformative change is health insurance, ...
On Thursday, the US Centers for Medicare & Medicaid Services (CMS) issued its proposal for covering radiofrequency- or ultrasound-based renal denervation for the treatment of uncontrolled hypertension ...
The Brief keeps Texas voters and political observers up to speed on the most essential coverage of their elected officials, the policies that shape their daily lives and the future of our great state.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback